Home visits aim to lower lead levels in nairobi kids
NCT ID NCT07401251
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a lead exposure prevention program originally designed for the US can work in Nairobi, Kenya. About 500 caregivers of children aged 1-6 will either get lead risk information only at a clinic or also receive a home visit with tailored advice. Researchers will measure changes in knowledge and risk-reduction behaviors over 9 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- home visit with tailored messages
- What this could lead to
- If successful, this could show that a home-visit program reduces lead exposure in children in low-resource settings.
- What could go wrong
- This is an early adaptation study, not a treatment trial. It may not show clear differences between groups, and results may not apply to other regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH BLOOD LEAD LEVELS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pumwani Hospital and Baba Ndogo Health Centre
Nairobi, Kenya
More trials for these conditions
Other studies related to the condition(s) this trial covers.